ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Elion Elected Member Of National Academy; Bleyer Heads M.D. Anderson Pediatrics

May 4, 1990

New Cooperative Group Funded

September 30, 1977

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

February 6, 1976

$293 Million NCI Budget Cut To Drop Grant Success Rate

May 10, 2013

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012